Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detecting lung cancer in plasma with the use of multiple genetic markers.

International journal of cancer - 1 Jan 2004

Andriani Francesca, Conte Davide, Mastrangelo Tiziana, Leon MariaElena, Ratcliffe Cathy, Roz Luca, Pelosi Giuseppe, Goldstraw Peter, Sozzi Gabriella, Pastorino Ugo

Abstract excerpt

Recent studies have demonstrated the possibility to detect genetic changes in plasma DNA of cancer patients. The goal of this study was to validate a panel of molecular markers for lung cancer detection in plasma DNA. Three markers, p53, FHIT and microsatellite alterations at loci on chromosome 3, were used to detect mutations in tumor and plasma DNA of 64 stage I-III non small cell lung cancer patients. p53...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acid Anhydride Hydrolases
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 3

Share to DNA, Neoplasm

Share to Genes, p53

Share to Genes, Tumor Suppressor

Share to Loss of Heterozygosity

Share to Neoplasm Proteins

Source

Identifiers

PMID: 14618621
DOI: 10.1002/ijc.11510

Genes

FHIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detecting lung cancer in plasma with the use of multiple genetic markers.PMID 14618621Read ↗

Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients.Semantic proximity Read ↗

Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancerSemantic proximity Read ↗

Quantitative detection of p53 mutations in plasma DNA from tobacco smokers.Semantic proximity Read ↗

Circulating DNA and lung cancer.Semantic proximity Read ↗

Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case–control study for risk assessmentSemantic proximity Read ↗

Microsatellite alterations in plasma DNA of small cell lung cancer patientsSemantic proximity Read ↗

Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance.Semantic proximity Read ↗

Somatic genetic changes accompanying lung tumor development.Semantic proximity Read ↗

Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patientsSemantic proximity Read ↗

TP53 gene mutations in plasma DNA of cancer patients.Semantic proximity Read ↗

Circulating Cell-Free DNA in Plasma/Serum of Lung Cancer Patients as a Potential Screening and Prognostic ToolSemantic proximity Read ↗

Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.